Business is booming.

Gilead Lifts Adjusted-Earnings Forecast Amid Remdesivir Demand



Gilead Sciences  (GILD) – Get Report shares rose on Monday after the biotechnology titan increased its earnings estimate for 2020 amid demand for its remdesivir covid treatment.





Source link

Leave A Reply

Your email address will not be published.